CELC Celcuity Inc. Insider Trading

Baker Bros. Advisors LP sold 3,100,000 shares at $102.50 for $317,750,000.00, reducing stake by 41.5%

Baker Bros. Advisors LP executed two separate sales totaling 3,100,000 shares on 2026-07-14 at $102.50, reducing its position from 7,472,852 shares to 4,372,852 shares (a -41.5% reduction). The timing is notable: the stock traded at $102.50 during the sale but now sits at $88.29 current price, placing it -41.5% from its 52-week high of $151.02. More significantly, CELC posted a full-year net income of $-52,841,000.00, reflecting persistent unprofitability. The insider's cross-ticker track record shows 20 prior open-market buys with 80% 90-day win rate and average 90-day return of +28.6%; however, this sell-side execution occurred while the company remains deeply unprofitable and stock momentum has turned negative (90-day change: -27.9%), diverging materially from the insider's historical pattern of participation in rising equities.

Director Dalvey David sells 27.8% of stake for $3.5M as CELC stock rallies off deep lows, extending his selling pattern.

Director Dalvey David executed a substantial sale of nearly 28% of his holdings while the stock is trading slightly below its recent highs and has surged significantly over the past three months. This transaction extends a marked pattern—David has sold shares nine consecutive times since mid-2025, with no offsetting purchases, suggesting a deliberate reduction in his exposure to the company. Critically, the company is burning substantial cash with significant net losses in both the latest quarter and full year, raising questions about whether the director's liquidation reflects concern about the company's cash burn trajectory. While the stock's recent momentum may have provided a favorable exit window, the absence of any insider buying and the consistent selling pattern create a mixed signal about conviction in the company's turnaround prospects.

Director Buller exercises 9,000 shares and immediately liquidates most via open-market sales at steep markups over exercise price.

Director Richard Buller exercised options to acquire 9,000 shares at $5.10, then sold 8,840 shares throughout the same trading day at prices ranging from $137 to $143—a 27-fold markup that appears driven by the timing opportunity rather than underlying conviction about the company's fundamentals. The scale of same-day exercise-and-sell (cashless or near-cashless transaction structure) is a mechanical feature of option vesting, not a reflection of directorial confidence in Celcuity's outlook. The stock has appreciated significantly over recent months and now trades slightly below its near-term high, but the company remains deeply unprofitable with substantial quarterly losses—a context that undercuts any narrative of bullish directorial sentiment. This filing meets the rule-based threshold for reporting but represents a routine option realization rather than a discretionary buy signal.

Director Dalvey David sold 20,000 shares of CELC at $120.03 on 2026-01-27; stock now $112.12.

Director Dalvey David sold 20,000 shares (20.0K shares) at $120.03 on 2026-01-27, reducing his holdings by 18.2% from 110,000 to 90,000 shares and realizing $2,400,538.00. The sale occurred near the stock's 52-week peak of $117.25 (within 4.4% of the high), following a strong 90-day rally of +45.3% and 30-day gain of +12.2%. His prior four measurable same-ticker sales at CELC (July 2025) all saw subsequent 90-day gains ranging from 54.1% to 63.9%, indicating a historical pattern of selling before continued upside rather than before declines. The company remains unprofitable with negative net income of $-43,804,000.00 over its most recent full fiscal year, creating a fundamental backdrop where insider selling near multi-month highs may warrant investor attention to whether this director's timing pattern persists or breaks.

Director Dalvey David sold 15,000 CELC shares at $100.00 on 2025-11-21; stock at 52-week high ($101.15), unprofitable company ($-43.8M net income).

Dalvey David sold 15,000 shares (15.0K shares) representing 12.0% of his pre-transaction holdings at $100.00, reducing his position to 110,000 shares. The sale occurs with the stock at its 52-week high of $101.15 after a 42.5% 30-day rally and 104.5% 90-day surge. However, his prior trades at CELC show a concerning pattern: none of his 5 prior sells at this ticker were well-timed (0 of 5 posted negative 90-day returns), meaning the stock consistently rose after his sales. Most critically, the company posted a full-year net income of $-43,804,000.00, indicating sustained unprofitability, which compounds the signal uncertainty—directors typically sell for liquidity or diversification reasons rather than fundamental conviction, yet the timing amid extreme momentum gains and operating losses warrants investor attention.

Baker Bros. Advisors LP bought 170,100 shares for $9.6M at $56.27 blended price; 10% holder now at 7.21M shares post-transaction.

Baker Bros. Advisors LP, a 10% holder in Celcuity, executed 4 separate purchases totaling 170,100 shares for $9,571,318.56 on 2025-09-08, increasing holdings by 2.4% to 7.21M shares. The $56.27 blended transaction price sits just 0.3% above the current price of $55.93, and within the 52-week range of $8.21–$62.53. The timing coincides with substantial recent momentum: the stock is up 19.9% over 30 days and up 345.3% over 90 days, meaning this insider purchase occurred well into a pronounced recovery phase. Notably, this 10% holder operates at a company currently unprofitable with net income of -$45.3M over its most recent full fiscal year, and the holder's cross-ticker buy history shows 20 prior purchases. The large committed capital and systematic volume suggest material conviction in the name at current levels, though the execution during an extended price rally and against a backdrop of ongoing losses warrants investor scrutiny of the underlying business fundamentals.

Director Dalvey David sold 109,325 shares at blended avg $44.07 for $4.8M under pre-arranged 10b5-1 plan adopted 2024-12-13

Dalvey David (Director) executed 7 separate sales totaling 109,325 shares for $4,818,369.81 on 2025-07-28 under a 10b5-1 trading plan adopted 2024-12-13. The sales reduced his holdings from 234,325 shares to 125,000 shares, a reduction of 46.7% of pre-transaction holdings. Because this transaction is part of a pre-arranged 10b5-1 plan, it is scheduled rather than discretionary, and reflects commitment made months prior rather than current-date judgment. The transaction is material in size and price realization, though the scheduled nature limits inference about insider conviction or market timing.